|
| 36969202 | Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response. | Front Immunol | 2023 |
| 37371840 | Rhythmic TMS as a Feasible Tool to Uncover the Oscillatory Signatures of Audiovisual Integration. | Biomedicines | 2023 |
| 34649298 | T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies. | Br J Haematol | 2022 |
| 35477725 | Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection. | Nat Commun | 2022 |
| 35581387 | Immune response in COVID-19: what is next? | Cell Death Differ | 2022 |
| 35659257 | Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak. | Virol J | 2022 |
| 36551945 | The Role of Alpha Oscillations among the Main Neuropsychiatric Disorders in the Adult and Developing Human Brain: Evidence from the Last 10 Years of Research. | Biomedicines | 2022 |
| 36614934 | Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option? | J Clin Med | 2022 |
| 36250806 | 'Disease X'-time to act now and prepare for the next pandemic threat. | Eur J Public Health | 2022 |
| 35971810 | The immune response as a double-edged sword: The lesson learnt during the COVID-19 pandemic. | Immunology | 2022 |
| 36139488 | SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production. | Cells | 2022 |
| 36348270 | Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. | Clin Proteomics | 2022 |
| 36009445 | Accuracy of EEG Biomarkers in the Detection of Clinical Outcome in Disorders of Consciousness after Severe Acquired Brain Injury: Preliminary Results of a Pilot Study Using a Machine Learning Approach. | Biomedicines | 2022 |
| 36153335 | Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results. | NPJ Vaccines | 2022 |
| 36183780 | Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality. | Life Sci | 2022 |
| 35128349 | The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals. | iScience | 2022 |
| 35127770 | Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021. | Front Med (Lausanne) | 2022 |
| 35238962 | Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis. | Eur J Clin Pharmacol | 2022 |
| 34991646 | Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney-liver transplantation. | Virol J | 2022 |
| 34863925 | Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. | Int J Infect Dis | 2022 |
| 34698501 | GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults. | Sci Transl Med | 2022 |
| 34547465 | COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models. | Mol Ther | 2022 |
| 34810244 | Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies. | Neurology | 2022 |
| 34719107 | Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients. | Liver Int | 2022 |
| 32975842 | COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. | J Med Virol | 2021 |
| 33713816 | Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. | Int J Infect Dis | 2021 |
| 33596245 | 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19. | PLoS One | 2021 |
| 33712574 | Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. | Cell Death Dis | 2021 |
| 33901654 | Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. | Int J Infect Dis | 2021 |
| 33672177 | Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing. | Int J Environ Res Public Health | 2021 |
| 33926462 | Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis. | Malar J | 2021 |
| 33926110 | Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. | Int J Mol Sci | 2021 |
| 33639176 | In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. | J Infect | 2021 |
| 33920222 | SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. | Viruses | 2021 |
| 33781803 | Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. | Antiviral Res | 2021 |
| 33918294 | Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen. | J Clin Med | 2021 |
| 33805832 | COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020. | Biomolecules | 2021 |
| 33800406 | Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. | Antibiotics (Basel) | 2021 |
| 33747397 | Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. | Mediterr J Hematol Infect Dis | 2021 |
| 33578018 | The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. | Int J Infect Dis | 2021 |
| 35011614 | Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. | Cells | 2021 |
| 34876157 | Multi-omics approach to COVID-19: a domain-based literature review. | J Transl Med | 2021 |
| 34440879 | Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection. | Cells | 2021 |
| 34809704 | Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers. | Biol Sex Differ | 2021 |
| 34571912 | Neuropathology and Inflammatory Cell Characterization in 10 Autoptic COVID-19 Brains. | Cells | 2021 |
| 34625750 | Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. | Nat Med | 2021 |
| 34480127 | Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. | Nat Med | 2021 |
| 34594343 | ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients. | Front Immunol | 2021 |
| 34447374 | COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial. | Front Immunol | 2021 |
| 34385425 | Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. | Cell Death Dis | 2021 |